Yamo Pharmaceuticals

‌

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Biotechnology, Pharmaceutical

Headquarters

New York, United States

Employees

1-10

Links

Org chart

Chuck Bramlage

Chief Executive Officer

Collapse

Eugene Prahin

Chief Financial Officer

Tracy Fischer

Senior Vice President – Regulatory Affairs & Quality

Uyen Nguyen

Vice President Of Clinical Research Operations

Brian Cahill

Chief Financial Officer

Teams

This company has no teams yet

Offices

HQ
1 person · 0 jobs

Similar companies

AbbVie

280 followers

Amgen

287 followers

Elanco

28 followers

Bristol-Myers Squibb

262 followers

Gilead Sciences

162 followers

Regeneron

134 followers

AtriCure

4 followers

Illumina

79 followers

Agilent Technologies

85 followers

Verily Life Sciences

46 followers

Alexion Pharmaceuticals

45 followers

Explore companies